Blueberry as a Potential Radiosensitizer for Treating Cervical Cancer
- 639 Downloads
Cervical cancer (CC) is a leading cause of death in women worldwide. Radiation therapy (RT) for CC is an effective alternative, but its toxicity remains challenging. Blueberry is amongst the most commonly consumed berries in the United States. We previously showed that resveratrol, a compound in red grapes, can be used as a radiosensitizer for prostate cancer. In this study, we found that the percentage of colonies, PCNA expression level and the OD value of cells from the CC cell line SiHa were all decreased in RT/Blueberry Extract (BE) group when compared to those in the RT alone group. Furthermore, TUNEL+ cells and the relative caspase-3 activity in the CC cells were increased in the RT/BE group compared to those in the RT alone group. The anti-proliferative effect of RT/BE on cancer cells correlated with downregulation of pro-proliferative molecules cyclin D and cyclin E. The pro-apoptotic effect of RT/BE correlated with upregulation of the pro-apoptotic molecule TRAIL. Thus, BE sensitizes SiHa cells to RT by inhibition of proliferation and promotion of apoptosis, suggesting that blueberry might be used as a potential radiosensitizer to treat CC.
KeywordsBlueberry extract Radiation Apoptosis Cervical cancer
This study was supported by grants from Des Moines University for Yujiang Fang, M.D., Ph.D. (IOER 05-14-01 and IOER 112-3749). Kristoffer T. Davidson was supported by Mentored Research Program from Des Moines University (IOER 112-3113).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 8.Matchett MD, MacKinnon SL, Sweeney MI, Gottschall-Pass KT, Hurta RA (2006) Inhibition of matrix metalloproteinase activity in DU145 human prostate cancer cells by flavonoids from lowbush blueberry (Vaccinium angustifolium): possible roles for protein kinase C and mitogen-activated protein-kinase-mediated events. J Nutr Biochem 17(2):117–125CrossRefPubMedGoogle Scholar
- 9.Montales MTE, Rahal OM, Kang J, Rogers TJ, Prior RL, Wu X, Simmen RC (2012) Repression of mammosphere formation of human breast cancer cells by soy isoflavone genistein and blueberry polyphenolic acids suggests diet-mediated targeting of cancer stem-like/progenitor cells. Carcinogenesis 33(3):652–660CrossRefPubMedGoogle Scholar
- 19.Bunea A, Rugină D, Sconţa Z, Pop RM, Pintea A, Socaciu C, Tăbăran F, Grootaert C, Struijs K, VanCamp J (2013) Anthocyanin determination in blueberry extracts from various cultivars and their antiproliferative and apoptotic properties in B16-F10 metastatic murine melanoma cells. Phytochemistry 95:436–444CrossRefPubMedGoogle Scholar
- 23.Qi C, Li S, Jia Y, Wang L (2014) Blueberry anthocyanins induce G2/M cell cycle arrest and apoptosis of oral cancer KB cells through down-regulation methylation of p53. Yi chuan= Hereditas/Zhongguo yi chuan xue hui bian ji 36(6):566–573Google Scholar
- 25.Lohachoompol V, Srzednicki G, Craske J (2004) The change of total anthocyanins in blueberries and their antioxidant effect after drying and freezing. Biomed Res Int 2004(5):248–252Google Scholar
- 34.Haie-Meder C, Morice P, Castiglione M, Group EGW (2009) Cervical cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(suppl_4):iv27–iv28Google Scholar
- 45.Nicholl MB, Ledgewood CL, Chen X, Bai Q, Qin C, Cook KM, Herrick EJ, Diaz-Arias A, Moore BJ, Fang Y (2014) Il-35 promotes pancreas cancer growth through enhancement of proliferation and inhibition of apoptosis: Evidence for a role as an autocrine growth factor. Cytokine 70(2):126–133CrossRefPubMedGoogle Scholar